Tyche Industries is an API manufacturer based in India. It holds 2 active US drug master files and 6 valid CEPs across a filed portfolio of 9 molecules. Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 16 August 2024 as OAI. Customs aggregates show $5.7M of exports covering 91 molecules to 17 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hyderabad, India | Not on file |
| Kakinada, India | 3004790309 |
| Molecule | Regulators | Docs |
|---|---|---|
| Sertraline | EDQM | 2 |
| Azelaic Acid | SFDA (Saudi Arabia) | 1 |
| Palonosetron | US FDA | 1 |
| Phenelzine | US FDA | 1 |
| Racecadotril | EDQM | 1 |
| Rupatadine | EDQM | 1 |
| Solifenacin Succinate | EDQM | 1 |
| Tamsulosin | EDQM | 1 |
| Tenofovir Disoproxil | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $640K | 10 |
| 2025 | Not reported | $5.7M | 17 |
| 2024 | Not reported | $4.7M | 16 |
| 2023 | Not reported | $5.9M | 16 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Tyche Industries comes back tiered against every other supplier able to file there.
Start for free